User profiles for Barbara Mühlemann

Barbara Mühlemann

Institute of Virology -- Charité Universitätsmedizin Berlin
Verified email at charite.de
Cited by 3051

Ancient hepatitis B viruses from the Bronze Age to the Medieval period

B Mühlemann, TC Jones, PB Damgaard, ME Allentoft… - Nature, 2018 - nature.com
Hepatitis B virus (HBV) is a major cause of human hepatitis. There is considerable uncertainty
about the timescale of its evolution and its association with humans. Here we present 12 …

Diverse variola virus (smallpox) strains were widespread in northern Europe in the Viking Age

B Mühlemann, L Vinner, A Margaryan, H Wilhelmson… - Science, 2020 - science.org
INTRODUCTION Variola virus (VARV), the causative agent of smallpox, is estimated to
have killed between 300 million and 500 million people in the 20​th century and was …

[HTML][HTML] Human monkeypox–After 40 years, an unintended consequence of smallpox eradication

…, S Lule, J Maclennan, A McCollum, B Mühlemann… - Vaccine, 2020 - Elsevier
Smallpox eradication, coordinated by the WHO and certified 40 years ago, led to the cessation
of routine smallpox vaccination in most countries. It is estimated that over 70% of the world…

Estimating infectiousness throughout SARS-CoV-2 infection course

TC Jones, G Biele, B Mühlemann, T Veith, J Schneider… - Science, 2021 - science.org
INTRODUCTION Although post facto studies have revealed the importance of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission from presymptomatic, …

[HTML][HTML] Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series

…, J Schneider, T Veith, B Mühlemann… - The Lancet Infectious …, 2020 - thelancet.com
Background In December, 2019, the newly identified severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, causing COVID-19, a respiratory …

[HTML][HTML] Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study

…, T Bleicker, ML Schmidt, B Mühlemann… - The Lancet …, 2021 - thelancet.com
Background Antigen point-of-care tests (AgPOCTs) can accelerate SARS-CoV-2 testing. As
some AgPOCTs have become available, interest is growing in their utility and performance. …

[HTML][HTML] Defining the risk of SARS-CoV-2 variants on immune protection

…, VD Menachery, DC Montefiori, B Mühlemann… - Nature, 2022 - nature.com
The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants jeopardizes the protective antiviral immunity induced after infection or …

An analysis of SARS-CoV-2 viral load by patient age

TC Jones, B Mühlemann, T Veith, G Biele… - MedRxiv, 2020 - medrxiv.org
As children are under-represented in current studies aiming to analyse transmission of
SARS-coronavirus 2 (SARS-CoV-2), their contribution to transmission is unclear. Viral load, as …

Mapping SARS-CoV-2 antigenic relationships and serological responses

SH Wilks, B Mühlemann, X Shen, S Türeli… - Science, 2023 - science.org
During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic,
multiple variants escaping preexisting immunity emerged, causing reinfections of previously …

[HTML][HTML] Humoral immune escape by current SARS-CoV-2 variants BA. 2.86 and JN. 1, December 2023

LM Jeworowski, B Mühlemann, F Walper… - …, 2024 - eurosurveillance.org
Variant BA.2.86 and its descendant, JN.1, of SARS-CoV-2 are rising in incidence across
Europe and globally. We isolated recent JN.1, BA.2.86, EG.5, XBB.1.5 and earlier variants. We …